Cargando…

Extended follow‐up after wearable cardioverter‐defibrillator period: the PROLONG‐II study

AIM: The wearable cardioverter‐defibrillator (WCD) is used for temporary protection from sudden cardiac death (SCD) in patients with newly diagnosed heart failure with reduced ejection fraction before considering an implantable cardioverter‐defibrillator (ICD). However, the prognostic significance o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mueller‐Leisse, Johanna, Brunn, Johanna, Zormpas, Christos, Hohmann, Stephan, Hillmann, Henrike Aenne Katrin, Eiringhaus, Jörg, Bauersachs, Johann, Veltmann, Christian, Duncker, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712878/ https://www.ncbi.nlm.nih.gov/pubmed/34480414 http://dx.doi.org/10.1002/ehf2.13586

Ejemplares similares

Feasibility and First Results of Heart Failure Monitoring Using the Wearable Cardioverter–Defibrillator in Newly Diagnosed Heart Failure with Reduced Ejection Fraction
por: Hillmann, Henrike Aenne Katrin, et al.
Publicado: (2021)

Delayed Improvement of Left Ventricular Function in Newly Diagnosed Heart Failure Depends on Etiology—A PROLONG-II Substudy
por: Mueller-Leisse, Johanna, et al.
Publicado: (2022)

Changes in eligibility for a subcutaneous cardioverter-defibrillator after implantation of a left ventricular assist device–A prospective analysis
por: Zormpas, Christos, et al.
Publicado: (2023)

Premature end of service of implantable cardioverter-defibrillator by magnetic interference with left-ventricular assist device
por: Eiringhaus, Jörg, et al.
Publicado: (2021)

Eligibility for subcutaneous implantable cardioverter-defibrillator in patients with left ventricular assist device
por: Zormpas, Christos, et al.
Publicado: (2020)

Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease
por: Zormpas, Christos, et al.
Publicado: (2021)

Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator—The PROLONG Study
por: Duncker, David, et al.
Publicado: (2017)

Cardiac Rhythm Monitoring Using Wearables for Clinical Guidance before and after Catheter Ablation
por: Hillmann, Henrike Aenne Katrin, et al.
Publicado: (2022)

Depressive Symptoms and Quality of Life in Patients With Heart Failure and an Implantable Cardioverter-Defibrillator
por: Zormpas, Christos, et al.
Publicado: (2022)

Author reply: S‐ICD eligibilities in adults with congenital heart disease
por: Zormpas, Christos, et al.
Publicado: (2021)

Similarly high success and low complication rates of catheter ablation for idiopathic premature ventricular contractions from the left and right ventricular outflow tract
por: Mueller-Leisse, J, et al.
Publicado: (2023)

Prediction of ablation success of idiopathic premature ventricular contractions with an inferior axis using the twelve-lead electrocardiogram
por: Mueller-Leisse, J, et al.
Publicado: (2023)

Usage of the wearable cardioverter-defibrillator during pregnancy
por: Olic, J.-Jacqueline, et al.
Publicado: (2022)

Acute echocardiographic and electrocardiographic effects of triggered left ventricular pacing
por: Pfeffer, Tobias Jonathan, et al.
Publicado: (2022)

Role of the Wearable Defibrillator in Newly Diagnosed Heart Failure
por: Duncker, David, et al.
Publicado: (2018)

Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry
por: Veltmann, Christian, et al.
Publicado: (2020)

Correction to: Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry
por: Veltmann, Christian, et al.
Publicado: (2020)

First experience with the wearable cardioverter defibrillator in the Netherlands
por: Knops, R. E., et al.
Publicado: (2011)

Wearable cardioverter defibrillator: Bridge or alternative to implantation?
por: Barraud, Jeremie, et al.
Publicado: (2017)

Multiparameter Monitoring with a Wearable Cardioverter Defibrillator
por: Rohrer, Ursula, et al.
Publicado: (2021)

An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting
por: Kishihara, Jun, et al.
Publicado: (2016)

Bridge to avoid ICD implantation with wearable cardioverter defibrillators
por: Zoppo, Franco, et al.
Publicado: (2020)

A Tragic Case of Wearable Cardioverter-Defibrillator Failure
por: Vinas, Ariel, et al.
Publicado: (2021)

Phantom Shocks Associated With a Wearable Cardioverter Defibrillator
por: Delle Donna, Paul, et al.
Publicado: (2021)

Experience with a Wearable Cardioverter-defibrillator in 436 Patients
por: Nägele, Herbert, et al.
Publicado: (2022)

Wearable cardioverter‐defibrillator: friend or foe in suspected myocarditis?
por: Blaschke, Florian, et al.
Publicado: (2021)

Extended use of the wearable cardioverter-defibrillator in patients at risk for sudden cardiac death
por: Kutyifa, Valentina, et al.
Publicado: (2018)

Extended Use of the Wearable Cardioverter-Defibrillator: Which Patients Are Most Likely to Benefit?
por: Kovacs, Boldizsar, et al.
Publicado: (2018)

Defibrillators for prevention from sudden cardiac death: is it that easy?
por: Duncker, David, et al.
Publicado: (2020)

Sudden Cardiac Arrest in Hemodialysis Patients with Wearable Cardioverter Defibrillator
por: Wan, Chingping, et al.
Publicado: (2013)

Oversensing of the wearable cardioverter defibrillator during bipolar ventricular stimulation
por: Manninger, Martin, et al.
Publicado: (2017)

Wearable Cardioverter Defibrillator　― Initial Experience in the Outpatient Setting in Japan ―
por: Horiguchi, Ai, et al.
Publicado: (2020)

The wearable cardioverter-defibrillator is not needed for most high-risk patients
por: Bhatt, Advay G., et al.
Publicado: (2020)

The wearable cardioverter-defibrillator is needed for most high-risk patients
por: Lee, Byron K.
Publicado: (2020)

Update on Wearable Cardioverter Defibrillator: A Comprehensive Review of Literature
por: Alsamman, Mrhaf, et al.
Publicado: (2022)

The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital
por: Sinha, Anil-Martin, et al.
Publicado: (2020)

Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry
por: El-Battrawy, Ibrahim, et al.
Publicado: (2022)

A wearable cardioverter defibrillator with a low false alarm rate
por: Poole, Jeanne E., et al.
Publicado: (2022)

The wearable cardioverter‐defibrillator—Improving comfort and reaching towards noise immunity
por: Varma, Niraj
Publicado: (2022)

Epidural Blood Patch Placement with Patient Wearing Wearable Cardioverter Defibrillator: To be or Not to be
por: Gupta, Deepak
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_adlr4o2bddpq9ln3gbcmibnu96